Inhibrx Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 05/15/2025 | 1.79 M | $25.01 M | 0.00% | 11.56% |
| SANOFI | 05/06/2025 | 1.16 M | $16.20 M | 0.00% | 7.49% |
| PERCEPTIVE ADVISORS LLC | 05/15/2025 | 1.06 M | $14.89 M | 0.00% | 7.35% |
| HIGHTOWER ADVISORS, LLC | 05/13/2025 | 871.75 K | $12.20 M | 11.51% | 5.64% |
| BLACKROCK, INC. | 05/02/2025 | 832.73 K | $11.65 M | 0.11% | 5.38% |
| SOFINNOVA INVESTMENTS, INC. | 05/15/2025 | 697.92 K | $9.76 M | 32.38% | 4.82% |
| VANGUARD GROUP INC | 05/09/2025 | 588.32 K | $8.23 M | -3.19% | 3.80% |
| PFM HEALTH SCIENCES, LP | 05/15/2025 | 439.28 K | $6.15 M | 224.08% | 3.03% |
| WOODLINE PARTNERS LP | 05/15/2025 | 358.44 K | $5.01 M | 100.00% | 2.32% |
| SLOTNIK CAPITAL, LLC | 05/13/2025 | 286.96 K | $4.01 M | -26.04% | 1.86% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 255.34 K | $3.57 M | -1.18% | 1.76% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 260.03 K | $3.64 M | 1.92% | 1.68% |
| CAPTION MANAGEMENT, LLC | 05/15/2025 | 199.51 K | $2.79 M | -0.20% | 1.29% |
| ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 192.50 K | $2.69 M | 34.17% | 1.24% |
| STATE STREET CORP | 05/15/2025 | 172.90 K | $2.42 M | -1.97% | 1.12% |
| KENNEDY CAPITAL MANAGEMENT LLC | 05/13/2025 | 164.98 K | $2.31 M | -0.43% | 1.07% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 144.18 K | $2.02 M | 0.00% | 0.93% |
| ARROWMARK COLORADO HOLDINGS LLC | 05/15/2025 | 139.68 K | $1.95 M | -13.19% | 0.90% |
| NORTHERN TRUST CORP | 05/13/2025 | 116.51 K | $1.63 M | 0.35% | 0.75% |
| 05/14/2025 | 75.93 K | $1.06 M | 100.00% | 0.49% | |
| 05/15/2025 | 64.22 K | $898.40 K | 0.00% | 0.44% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 52.87 K | $739.69 K | -27.02% | 0.34% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 52.80 K | $738.67 K | 2.63% | 0.34% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 47.91 K | $670.22 K | -47.48% | 0.31% |
| IKARIAN CAPITAL, LLC | 05/15/2025 | 42.12 K | $589.29 K | 0.00% | 0.29% |
| 04/10/2025 | 38.65 K | $540.67 K | -50.41% | 0.25% | |
| FMR LLC | 05/12/2025 | 37.35 K | $522.48 K | -3.64% | 0.24% |
| MORGAN STANLEY | 05/15/2025 | 36.90 K | $516.23 K | -7.09% | 0.24% |
| YAKIRA CAPITAL MANAGEMENT, INC. | 05/14/2025 | 36.20 K | $506.37 K | 0.00% | 0.23% |
| TABOR ASSET MANAGEMENT, LP | 05/05/2025 | 36.20 K | $506.37 K | 100.00% | 0.23% |
| MURCHINSON LTD. | 05/15/2025 | 33.79 K | $472.72 K | 0.00% | 0.23% |
| CITADEL ADVISORS LLC | 05/15/2025 | 35.50 K | $496.65 K | 2.23% | 0.23% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 35.50 K | $496.65 K | 84.90% | 0.23% |
| BIRCHVIEW CAPITAL, LP | 05/15/2025 | 32.11 K | $449.22 K | 0.00% | 0.22% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 32.66 K | $456.87 K | 0.00% | 0.21% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 28.23 K | $394.94 K | 0.00% | 0.18% |
| ARBITER PARTNERS CAPITAL MANAGEMENT LLC | 05/13/2025 | 28.10 K | $393.05 K | 0.00% | 0.18% |
| UBS GROUP AG | 05/13/2025 | 27.47 K | $384.28 K | 54.69% | 0.18% |
| RUSSELL INVESTMENTS GROUP, LTD. | 05/13/2025 | 27.03 K | $378.15 K | -50.26% | 0.17% |
| JANE STREET GROUP, LLC | 05/19/2025 | 26.30 K | $367.94 K | -70.26% | 0.17% |
| 05/12/2025 | 25.02 K | $350.04 K | 100.00% | 0.16% | |
| MERIDIAN WEALTH ADVISORS, LLC | 05/05/2025 | 25.00 K | $349.75 K | 0.00% | 0.16% |
| EMPIRICAL FINANCIAL SERVICES, LLC D.B.A. EMPIRICAL WEALTH MANAGEMENT | 05/08/2025 | 22.58 K | $315.95 K | 0.00% | 0.15% |
| JBF CAPITAL, INC. | 05/08/2025 | 20.95 K | $293.08 K | 0.00% | 0.14% |
| CI PRIVATE WEALTH, LLC | 05/14/2025 | 20.46 K | $286.17 K | -0.18% | 0.13% |
| MARINER, LLC | 05/15/2025 | 18.67 K | $261.15 K | 100.00% | 0.12% |
| ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 17.93 K | $250.84 K | 0.00% | 0.12% |
| 05/14/2025 | 17.81 K | $249.16 K | -63.95% | 0.12% | |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 17.17 K | $240.14 K | -70.12% | 0.11% |
| XTX TOPCO LTD | 05/08/2025 | 16.92 K | $236.68 K | 100.00% | 0.11% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Inhibrx Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 111 institutional investors and hedge funds held shares of Inhibrx Biosciences, Inc.. The most heavily invested institutionals were:
VIKING GLOBAL INVESTORS LP: 1.79 M
Sanofi: 1.16 M
PERCEPTIVE ADVISORS LLC: 1.06 M
HighTower Advisors, LLC: 871,754
BlackRock, Inc.: 832,732
Sofinnova Investments, Inc.: 697,916
69.99% of Inhibrx Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 11.45 M shares in the last 24 months. This purchase volume represents approximately $167.23 M in transactions.